Companies Owned by Mark Cuban: Stakes, Investments & Exits

Mark Cuban's portfolio has shifted from one dominant sports asset toward healthcare, media and minority investing. Cost Plus Drugs is now the clearest operating focus. Its model replaces opaque rebate economics with a disclosed markup and direct pharmacy relationship, giving consumers a simple value proposition. The financial opportunity is significant because generic-drug distribution is large and inefficient, but scale requires reliable sourcing, pharmacy operations, customer service and partnerships that can lower acquisition costs without compromising transparency.

2929 Entertainment provides a second controlled platform through shared ownership with Todd Wagner. Its value lies in film rights, distribution capabilities and a long operating history rather than the size of a physical theater estate, since Landmark Theatres was sold in 2018. Media cash flow is project-driven and volatile, so the portfolio benefits when distribution libraries and recurring licensing offset production risk. AXS TV is a minority interest after the 2019 control sale and belongs outside the controlled-company count.

The Mavericks transaction changed Cuban's liquidity and governance profile. The 2023 majority sale converted a large portion of an illiquid franchise into cash while leaving him about 27 percent exposure to future team appreciation. That retained stake does not carry operating control, and an option held by the buyer group can further reduce it. We therefore treat it as a passive sports asset whose value depends on franchise economics, arena strategy and majority-owner decisions.

Shark Tank expanded Cuban's venture portfolio but also produced many small, illiquid positions that require different underwriting from Cost Plus Drugs or the Mavericks. His edge is distribution, negotiation and willingness to support founder-led products; the risk is that attention cannot substitute for repeat purchase, margin or governance. The portfolio's strongest structure is a liquid base created by exits and the Mavericks sale, selective operating involvement in Cost Plus Drugs, and capped exposure to high-variance media and venture investments.

Capital allocation should reflect Cuban's different advantages in each segment. Public advocacy can accelerate Cost Plus Drugs, deal access can improve venture sourcing and sports ownership can provide scarce-asset exposure. None of those advantages removes the need for cash-flow discipline. We would require each controlled company to fund growth against measurable unit economics and each minority position to justify its monitoring burden, governance protection and path to liquidity. Portfolio reporting should also distinguish realized distributions from paper appreciation, since the two provide very different capacity to fund new commitments.

The most important fact about Cuban's control today is the one most readers still get wrong: he does not control the Dallas Mavericks. He sold majority ownership to Miriam Adelson and Patrick Dumont in a deal that closed in December 2023, and Dumont, not Cuban, now serves as Governor. The original understanding, reported at the time of the sale and reiterated by Cuban himself, was that he would retain control of basketball operations even after selling the business side. That arrangement did not survive in practice; by mid-2024, general manager authority ran through Dumont rather than Cuban, and Cuban has publicly said he had no control over the February 2025 trade of Luka Doncic, a decision he has said he regrets not being able to prevent.

That loss of control has become an active, unresolved dispute rather than a settled fact. In July 2026, Cuban filed a Texas pre-suit legal petition against Dumont alleging adversarial business practices and seeking discovery on the team's arena and entertainment-district plans, prompting a pointed public response from Dumont questioning why he would cede control of what he called a 4 billion dollar asset. Cuban withdrew that petition in August 2026 without prejudice, meaning he retains the ability to refile, and his attorneys have indicated he intends to keep pursuing access to planning information. As of this writing, the dispute is unresolved rather than closed.

The company's structure as a public benefit corporation, and its continued expansion through partnerships like the 2026 TrumpRx deal, suggest an operationally engaged relationship rather than a passive investment.

His other current positions, minority stakes in the Athletics and the Brampton Honey Badgers, along with his AXS TV and 2929 Entertainment holdings, are explicitly minority or co-owned positions where Cuban does not hold sole controlling authority. Taken together, Cuban's control picture in 2026 is meaningfully reduced from the sole-owner-and-operator profile he held for over two decades at the Mavericks.

Cuban's influence differs sharply by asset. He is an active co-founder at Cost Plus Drugs, shares ownership at 2929, and is a noncontrolling investor in the Mavericks. That distinction determines which outcomes he can change. Cost Plus requires formal pharmacy and compliance leadership; 2929 requires partner alignment; sports minority positions require contractual information and exit rights. We see clear decision rights as essential because a strong public persona can otherwise be mistaken for legal control.

Cuban's investment activity is genuinely broad, spanning roughly 246 completed Shark Tank deals plus a smaller number of positions built outside the show, though the level of disclosure varies sharply across them. The Shark Tank portfolio is the best-documented piece: about 33 million dollars invested across nearly a decade and a half on the show, concentrated in consumer products companies like BeatBox Beverages and Tower Paddleboards, the latter of which alone has paid him over 1 million dollars in dividends.

His 2026 sports investments show a different, more targeted pattern: a minority stake in the Athletics baseball franchise through Harbinger Sports Partners, where Cuban serves as General Partner and President rather than lead investor, that role belonging to Rashaun Williams, and a smaller minority buy-in to the Brampton Honey Badgers, a Canadian Elite Basketball League team. Neither disclosed a specific percentage stake or dollar amount, which is consistent with how most of Cuban's post-Mavericks sports investments have been reported.

What is notably absent is any comprehensive, independently verifiable list of his broader angel or venture activity beyond Shark Tank.

Taken as a whole, Cuban's investment style reads as broad and high-volume rather than concentrated: many smaller, often minority positions across consumer products, sports, and now healthcare, in contrast to the single large, controlling position the Mavericks represented for over two decades before its 2023 sale.

The venture book should be managed as a portfolio, not a collection of television stories. Follow-on decisions need evidence of gross margin, repeat demand, working-capital discipline and founder execution. Sports investments require a different lens centered on media rights, venue economics, league governance and scarcity value. Cuban's advantage is access and commercialization support, but the cost of small positions is monitoring complexity. Concentrating additional capital in proven operators can improve realized returns.

Healthcare partnerships should be evaluated on access to covered lives, prescription conversion and retained gross profit rather than announcements. Venture and consumer deals need repeat purchase and disciplined inventory. Sports stakes require league-level diligence and minority protections. Applying those separate scorecards would prevent a broad personal brand from becoming a substitute for underwriting and would identify which investments merit additional capital after their initial publicity fades.

Cuban's exit history includes both his career-defining early sale and, more recently, the far larger and more consequential 2023 sale of the Dallas Mavericks. His first exit, MicroSolutions, sold to CompuServe for 6 million dollars in 1990, is small by comparison to everything that followed but funded the start of his career as a repeat entrepreneur. His second, the 1999 sale of Broadcast.com to Yahoo! for 5.7 billion dollars in stock, is the transaction that made him a billionaire, and his decision to hedge much of that Yahoo stock shortly afterward is often credited with protecting his fortune from Yahoo's later collapse in the dot-com crash.

The Mavericks sale, by contrast, is not a clean exit in the traditional sense, since Cuban retained a roughly 27 percent minority stake rather than selling entirely. Forbes frames the transaction as netting him roughly 2 billion dollars pre-tax against the majority stake sold, and the sale agreement reportedly includes a provision letting the Adelson and Dumont group buy up to an additional 20 percent of Cuban's remaining stake within four years of the 2023 close, a mechanism that could reduce his position to as little as roughly 7 percent by around the end of 2027 if exercised.

Two smaller, cleaner exits round out his recent history: the December 2018 sale of Landmark Theatres, the arthouse cinema chain co-owned through 2929 Entertainment, to Cohen Media Group, and the September 2019 sale of majority control in AXS TV and HDNet to Anthem Sports & Entertainment, after which Cuban retained a minority stake rather than exiting entirely, similar in structure to how the Mavericks deal later played out.

The pattern across all of these, apart from MicroSolutions and Broadcast.com, is Cuban trading full control for partial liquidity while keeping a smaller ongoing stake, rather than exiting businesses completely. That makes the Mavericks the clearest and most consequential recent example of a broader habit: he appears more willing to sell control than to sell out entirely.

Cuban's best exits paired favorable market structure with risk reduction. The Broadcast.com stock sale transferred a richly valued internet asset, and a subsequent hedge protected much of the proceeds. The Mavericks sale monetized control while retaining minority upside. Landmark and AXS TV narrowed fixed-cost and operating exposure in media. The common lesson is that partial exits can preserve optionality, but only if governance rights, buyer options and tax consequences are incorporated into the value of what remains.